Health2Tech

Why US Healthcare Is Broken — and Why AI Alone Won’t Save It | Dr. David LevyIn this episode of Digital Health Interviews, Alex Koshykov speaks with Dr. David Levy, physician, entrepreneur, former PwC global healthcare leader, and founder of Franklin Health. Dr. Levy explains why the U.S. healthcare system is in worse shape today than when he started 40 years ago, why employer-based health insuran...

Jason Scharf is one of the loudest voices in Austin’s growing health tech and biotech ecosystem — and in this episode of Digital Health Interviews, we go deep into why Austin is rapidly becoming one of the most important innovation hubs in healthcare. We discuss the future of healthcare innovation, GLP-1 drugs like Ozempic and Zepbound, CRISPR cures, AI in healthcare, the broken healthcare busines...

In this episode of Digital Health Interviews, we sit down with David Jabotovsky — a soon-to-be pain medicine fellow with an MD/MBA background — to unpack the reality of modern medicine from the front lines. From physician burnout and broken incentives to AI scribes, clinical decision support, and the growing power of payers, this conversation goes deep into what doctors actually experience—and whe...

In this episode of Digital Health Interviews, we sit down with Sean Day, early-stage investor at Rock Health Capital, to break down what actually matters when building and funding digital health startups in 2026.

A conversation with Rami Ajjuri, a healthcare product leader, on why healthcare UI/UX still fails clinicians, what founders consistently get wrong, and how AI is reshaping digital health. We also explore system-level questions around competition, patient outcomes, and practical advice for founders building healthcare technology today.

Phase Capital founder Kavya Sharman explains the difference between techbio and biotech and where GenAI is already changing lab work. We discuss autonomous labs, realistic disease “cure” timelines, and her thesis as an investor.

AMA president Dr. Jesse Ehrenfeld talks about medical debt, AI’s role in reducing burnout, value-based care, and global AI adoption differences. We also hear why he continues to see patients despite major leadership roles.

NYC Health + Hospitals Chief Quality Officer Dr. Komal Bajaj shares a candid view on hospital pilots, AI expectations, and startup red flags. We talk about quality, safety, and how founders can win (and keep) clinical partners.

HealthX Ventures principal Laura Hilty reflects on her journey from Epic operator to health tech investor. We discuss scalability challenges, what investors truly look for, and realistic roles for AI in care.

KeyCare CEO Dr. Lyle Berkowitz shares his “SAD” principle for fixing healthcare workflows: Simplify, Automate, and Delegate. We cover ambient AI, value-based care incentives, and why telehealth still underperforms its potential.

Cleveland Clinic’s Jennifer Owens opens up about driving AI programs inside a major health system. We talk decision-making in large organizations, GenAI use cases, model risks, and the future of US healthcare.

THYNK co-founder Jennifer Gentile explores game-based tools for brain function and mental health. We discuss telehealth’s early days, hardware integration, safety concerns, and funding strategies.

Carenostics COO Kanishka Rao explains how his company uses AI to detect chronic diseases earlier inside health systems. We cover grants, EHR integrations, incentives for prevention, and future expansion plans.

Rock Health’s Julia Croxen reviews the digital health market of 2024 and shares predictions for 2025. We talk investment trends, scaling challenges, Rock Health’s maturity curve, and what winning startups did differently.

Dr. Joseph Kvedar explains why home-based care and telehealth are central to the next phase of US healthcare. We cover business models, AI use cases, and what startups must nail to succeed in virtual care.

MindMics founder Dr. Anna Barnacka describes how she moved from astrophysics to in-ear cardiovascular monitoring. We talk about building novel sensors, high-fidelity data, and growing a deep-tech health startup.

RxE2 CEO Gerald Finken talks about using pharmacists and AI to redesign clinical trials. We discuss post-pandemic research, patient access, and how pharma companies adopt new trial models.

Former speech pathologist Bailey Morgan explains how her clinical background shapes her role as a Clinical Product Specialist. We dive into selling to health systems, long sales cycles, and AI adoption in care.

OBG Access founder Nish Varma shares his journey from finance to maternal health innovation. We talk regulations, entering new markets, childbirth safety devices, and advice for MedTech founders.

FINN Partners’ Ritesh Patel reflects on decades in digital health, from early pilots to today’s hype cycle. We explore value-based care, rural health equity, and whether tech is actually fixing the system.

Advisor and venture studio leader Vadim Gordin argues why now is still a great time to build in digital health. We discuss founder mistakes, integration challenges, and what separates standout teams from the rest.

Infinitus founder Ankit Jain explains how AI can automate healthcare workflows and where the real value lies. We talk call automation, job impact, VC attitudes, and the future of AI in health operations.

Sergei Polevikov offers an unfiltered take on US healthcare, EHRs, primary care, VC behavior, and AI hype. This is a frank conversation about what’s broken, what’s promising, and what founders should avoid.

Entrepreneur Lisa Voronkova shares lessons from building medical and wellness devices. We cover accelerator programs, taking a device from idea to market, and the realities of MedTech entrepreneurship.

Advisor Amir Lahav talks about how pharma is embracing digital health, from RPM devices to new kinds of clinical trials. We explore startup–pharma partnerships and what has really changed post-COVID.